$USNU
Elite Health Systems Inc.

2021 Q2 Form 10-Q Financial Statement

#000114036121027937 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $0.00 $596.0K
YoY Change -100.0% -27.76%
Cost Of Revenue $0.00 $116.0K
YoY Change -100.0% 38.1%
Gross Profit $0.00 $480.0K
YoY Change -100.0% -35.22%
Gross Profit Margin 80.54%
Selling, General & Admin $249.0K $342.0K
YoY Change -27.19% -6.3%
% of Gross Profit 71.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $249.0K $458.0K
YoY Change -45.63% 2.0%
Operating Profit -$249.0K $138.0K
YoY Change -280.43% -63.3%
Interest Expense $1.000K $7.000K
YoY Change -85.71% -72.0%
% of Operating Profit 5.07%
Other Income/Expense, Net -$136.0K
YoY Change
Pretax Income -$385.0K $60.00K
YoY Change -741.67% -171.43%
Income Tax $232.0K $15.00K
% Of Pretax Income 25.0%
Net Earnings -$617.0K $45.00K
YoY Change -1471.11% -176.27%
Net Earnings / Revenue 7.55%
Basic Earnings Per Share -$0.08 $0.01
Diluted Earnings Per Share -$0.08 $0.01
COMMON SHARES
Basic Shares Outstanding 7.792M 7.792M
Diluted Shares Outstanding 7.792M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.820M $1.989M
YoY Change 41.78% 22.93%
Cash & Equivalents $2.820M $1.989M
Short-Term Investments
Other Short-Term Assets $89.00K $98.00K
YoY Change -9.18% -51.0%
Inventory
Prepaid Expenses
Receivables $0.00 $233.0K
Other Receivables $0.00 $984.0K
Total Short-Term Assets $2.909M $3.304M
YoY Change -11.96% 6.65%
LONG-TERM ASSETS
Property, Plant & Equipment $77.00K $112.0K
YoY Change -31.25% -22.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $164.0K $250.0K
YoY Change -34.4% 17.37%
Other Assets $923.0K $1.641M
YoY Change -43.75% -38.75%
Total Long-Term Assets $1.164M $1.753M
YoY Change -33.6% -37.9%
TOTAL ASSETS
Total Short-Term Assets $2.909M $3.304M
Total Long-Term Assets $1.164M $1.753M
Total Assets $4.073M $5.057M
YoY Change -19.46% -14.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $135.0K $236.0K
YoY Change -42.8% 17.41%
Accrued Expenses $41.00K $38.00K
YoY Change 7.89% 11.76%
Deferred Revenue $554.0K
YoY Change -2.29%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $323.0K
YoY Change -100.0% -76.78%
Total Short-Term Liabilities $366.0K $1.586M
YoY Change -76.92% -27.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $56.00K $98.00K
YoY Change -42.86% -27.94%
Total Long-Term Liabilities $56.00K $98.00K
YoY Change -42.86% -78.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $366.0K $1.586M
Total Long-Term Liabilities $56.00K $98.00K
Total Liabilities $422.0K $1.684M
YoY Change -74.94% -39.49%
SHAREHOLDERS EQUITY
Retained Earnings $195.0K
YoY Change -587.5%
Common Stock $3.178M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.651M $3.373M
YoY Change
Total Liabilities & Shareholders Equity $4.073M $5.057M
YoY Change -19.46% -14.59%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$617.0K $45.00K
YoY Change -1471.11% -176.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $421.0K $231.0K
YoY Change 82.25% -52.66%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$144.0K $321.0K
YoY Change -144.86% 453.45%
Cash From Investing Activities -$144.0K $321.0K
YoY Change -144.86% 453.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -297.0K
YoY Change -100.0% -16.34%
NET CHANGE
Cash From Operating Activities 421.0K 231.0K
Cash From Investing Activities -144.0K 321.0K
Cash From Financing Activities 0.000 -297.0K
Net Change In Cash 277.0K 255.0K
YoY Change 8.63% 33.51%
FREE CASH FLOW
Cash From Operating Activities $421.0K $231.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
208-8998
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7792185
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
346000
CY2021Q2 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
0
CY2020Q4 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
532000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
89000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3651000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3686000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001089815
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-15586
dei Entity Registrant Name
EntityRegistrantName
U.S. NeuroSurgical Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5370333
dei Entity Address Address Line1
EntityAddressAddressLine1
2400 Research Blvd, Suite 325
dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
138000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-274000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
288000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
667000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
790000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
654000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
596000
CY2021Q2 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
0
CY2020Q2 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
116000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
249000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
342000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
249000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
458000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-249000
CY2021Q2 us-gaap Interest Expense
InterestExpense
1000
CY2020Q2 us-gaap Interest Expense
InterestExpense
7000
CY2021Q2 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
0
CY2020Q2 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
20000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-135000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-91000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-385000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
60000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-574000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
45000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1061000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1343000
us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
86000
us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
195000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
547000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
644000
us-gaap Operating Expenses
OperatingExpenses
633000
us-gaap Operating Expenses
OperatingExpenses
839000
us-gaap Operating Income Loss
OperatingIncomeLoss
428000
us-gaap Operating Income Loss
OperatingIncomeLoss
504000
us-gaap Interest Expense
InterestExpense
3000
us-gaap Interest Expense
InterestExpense
19000
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
8000
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
44000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-236000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
159000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
293000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
us-gaap Net Income Loss
NetIncomeLoss
-35000
us-gaap Net Income Loss
NetIncomeLoss
220000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
us-gaap Net Income Loss
NetIncomeLoss
-35000
us-gaap Net Income Loss
NetIncomeLoss
220000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
16000
usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-274000
usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-236000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
63000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
79000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-186000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-346000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-123000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-215000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-10000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
328000
usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
20000
usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
17000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
635000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
983000
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
232000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-170000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
36000
us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
532000
us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
436000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
244000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
338000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
89000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-667000
CY2020Q2 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
984000
CY2021Q2 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
0
CY2020Q2 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
0
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
112000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2030000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1335000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2820000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1989000
us-gaap Interest Paid Net
InterestPaidNet
3000
us-gaap Interest Paid Net
InterestPaidNet
18000
CY2021Q2 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
0
CY2021Q2 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
77000
CY2020Q2 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
1096000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
323000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45000
CY2021Q2 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
86000
CY2020Q2 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
448000
us-gaap Lease Cost
LeaseCost
14000
us-gaap Lease Income
LeaseIncome
7000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
22000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
46000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
24000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
92000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
86000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05850
usnu Renovation Installation And Operation Agreement Period
RenovationInstallationAndOperationAgreementPeriod
P14Y
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
158000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.22
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000

Files In Submission

Name View Source Status
0001140361-21-027937-index-headers.html Edgar Link pending
0001140361-21-027937-index.html Edgar Link pending
0001140361-21-027937.txt Edgar Link pending
0001140361-21-027937-xbrl.zip Edgar Link pending
brhc10027767_10q.htm Edgar Link pending
brhc10027767_10q_htm.xml Edgar Link completed
brhc10027767_ex31-1.htm Edgar Link pending
brhc10027767_ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usnu-20210630.xsd Edgar Link pending
usnu-20210630_cal.xml Edgar Link unprocessable
usnu-20210630_def.xml Edgar Link unprocessable
usnu-20210630_lab.xml Edgar Link unprocessable
usnu-20210630_pre.xml Edgar Link unprocessable